Figure 2 | Scientific Reports

Figure 2

From: Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis

Figure 2

Treatment effect of a standardised frankincense extract (SFE) on selected lipid mediators, neurofilament light chain, contrast enhancing lesion volume, and immunological outcomes in the SABA trial (n = 28 patients; n = 12 NEDA and n = 16 EDA patients). HC: healthy controls. Pre: baseline values before start of treatment, post: values after 8 months of continuous SFE treatment. ***p < 0.001, **p < 0.01, *p < 0.05.

Back to article page